Trial Profile
A multicenter phase II trial to investigate the effect of elafin on patients with esophagus carcinoma undergoing transthoracic esophagectomy.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Mar 2023
Price :
$35
*
At a glance
- Drugs Tiprelestat (Primary)
- Indications Carcinoma; Oesophageal cancer
- Focus Therapeutic Use
- Sponsors Proteo Biotech; tiakis Biotech
- 27 Mar 2015 New trial record